Resmed Inc. buy UBS Group AG
Start price
12.12.25
/
50%
€214.10
Target price
12.12.26
-
Performance (%)
0.37%
Price
12.12.25
€214.90
Summary
This prediction is currently active. Since the start of the prediction for Resmed Inc. the price has only changed by 0.37%. This prediction currently runs until 12.12.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Resmed Inc. | 0.37% |
| iShares Core DAX® | 0.734% |
| iShares Nasdaq 100 | -2.686% |
| iShares Nikkei 225® | -2.261% |
| iShares S&P 500 | -1.346% |
Comments by UBS_Group_AG for this prediction
In the thread Resmed Inc. diskutieren
ResMed (NYSE:RMD) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Ratings data for RMD provided by MarketBeat